Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5449 Journals
4179 Congresses
9600+ Unique Records

Anti-Cancer Drug Design


Title Abbreviation
Anticancer Drug Des
ISSN
0266-9536
Therapeutic Area
Readership
Oncologists, Pharmacologists
Scope
Anti-Cancer Drug Design publishes original research papers that feature the application of rationality of approach, rather than the mere listing of compounds synthesized and tested. These may involve, for example, structure-activity relationships, computational chemistry, structural biology, studies of drug pharmacokinetics and metabolism, drug targeting via antibody conjugates, or the design of anti-sense oligonucleotides.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Oxford University Press
To see more details about Anti-Cancer Drug Design, Subscribe Now!
Circulation Submission to Acceptance Acceptance to Print Publication Frequency

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
 
– Kait G
Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
– Michael K.
Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
- Weill Cornell Medical Library